Clinical Trials Browser

OTHER × Brain Neoplasms × poly ICLC × Clear all

NCT03223103 2025-09-10

Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma

Phase 1 Active not recruiting

Brain Neoplasms, Glioblastoma, Neoplasms

NCT01188096 2023-06-12

Poly-ICLC

Phase 2 Completed

23 enrolled 11 charts

Brain Neoplasms, Glioma, Neoplasms

NCT00058123 2018-08-21

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Phase 2 Completed

55 enrolled 8 charts

Astrocytoma, Brain Neoplasms, Ependymoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms